Fexofenadine Hydrochloride

Fexofenadine Hydrochloride, commonly known as Allegra, is a medication used to treat allergic conditions. This article examines various clinical trials investigating the use of Fexofenadine Hydrochloride in different formulations and conditions, including its bioequivalence, efficacy in treating allergic rhinitis, and potential applications in cardiovascular health.

Table of Contents

What is Fexofenadine Hydrochloride?

Fexofenadine Hydrochloride is a medication commonly used to treat allergic conditions. It belongs to a class of drugs called antihistamines, which help reduce allergy symptoms. Fexofenadine is known by various brand names, including Allegra and Dellegra[1][2].

Conditions Treated by Fexofenadine

Fexofenadine is primarily used to treat the following conditions:

  • Seasonal Allergic Rhinitis: This is commonly known as hay fever, which causes symptoms like sneezing, runny nose, and itchy eyes during specific seasons[2][3].
  • Cat-Induced Allergic Rhinitis: This refers to allergic reactions triggered by exposure to cats[4].
  • Chronic Idiopathic Urticaria: This is a condition characterized by recurring hives of unknown cause[5].

Dosage Forms and Combinations

Fexofenadine is available in various forms and combinations:

  • Tablets: Available in different strengths, including 30 mg, 60 mg, 120 mg, and 180 mg[5][6].
  • Orally Disintegrating Tablets: These are tablets that dissolve in your mouth without needing water[5].
  • Combination with Pseudoephedrine: Some formulations combine fexofenadine with pseudoephedrine, a decongestant, to provide additional relief from nasal congestion. These are often labeled as “Allegra-D” or similar names[7][1].

How Fexofenadine Works

Fexofenadine works by blocking the effects of histamine, a substance your body produces during an allergic reaction. By doing this, it helps reduce allergy symptoms such as sneezing, runny nose, itchy eyes, and hives. Unlike some older antihistamines, fexofenadine is less likely to cause drowsiness, making it a “non-sedating” antihistamine[2].

Efficacy Studies

Several studies have been conducted to evaluate the effectiveness of fexofenadine:

  • Onset of Action: Research has compared how quickly fexofenadine starts working compared to other allergy medications like montelukast (Singulair). These studies help determine how soon after taking the medication patients can expect relief[3].
  • Cat Allergy Relief: Studies have looked at how well fexofenadine prevents and controls allergy symptoms in people exposed to cat allergens[4].
  • Japanese Cedar Pollen Allergy: Research has examined the effectiveness of fexofenadine in treating allergic rhinitis caused by Japanese cedar pollen[1].

Safety Profile

Fexofenadine is generally considered safe for most people. However, like all medications, it can have side effects. Studies have been conducted to assess its safety, including:

  • Cognitive Performance: Research has compared the effects of fexofenadine on cognitive performance (like attention and reaction time) to other antihistamines and placebo, particularly in settings where alertness is crucial, such as among naval flight personnel[2].
  • Adverse Events: Clinical trials monitor for any adverse events (side effects) that occur during treatment with fexofenadine[1].

Ongoing Research

Interestingly, recent research has explored potential new uses for fexofenadine:

  • Heart Health: A study is investigating whether fexofenadine could have beneficial effects in patients who have had a heart attack (acute myocardial infarction). This research is based on findings that fexofenadine might help reduce heart fibrosis (scarring of the heart tissue) in animal studies. However, it’s important to note that this is still in the research phase and not an approved use for fexofenadine[8].

This potential new application highlights how medications can sometimes have unexpected benefits beyond their original intended use. However, patients should always use fexofenadine as directed by their healthcare provider and for its approved purposes.

Aspect Details
Primary Uses Treatment of allergic conditions (seasonal allergic rhinitis, chronic idiopathic urticaria)
Formulations Studied Regular tablets, orally disintegrating tablets, extended-release tablets (alone and in combination with Pseudoephedrine HCl)
Dosages Varying from 30 mg to 180 mg, depending on the formulation and study
New Potential Applications Treatment of cardiac fibrosis following acute myocardial infarction
Study Types Bioequivalence studies, efficacy studies, safety studies
Comparison Drugs Cetirizine, Montelukast, Placebo
Special Populations Healthy volunteers, allergic rhinitis patients, naval flight personnel, post-myocardial infarction patients
Key Outcomes Measured Bioequivalence parameters, allergy symptom scores, cognitive performance, cardiac function measures

Ongoing Clinical Trials on Fexofenadine Hydrochloride

  • Study on Dupilumab and Fexofenadine for Treating Indolent Systemic Mastocytosis with Skin Involvement in Patients

    Recruiting

    3 1 1
    Investigated diseases:
    Poland
  • Study on Fexofenadine Hydrochloride and Immunotherapy for Patients with Advanced Non-Small Cell Lung Cancer

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria
  • Study on Long-Term Safety of mRNA-3705 for Patients with Methylmalonic Acidemia (MMA)

    Recruiting

    2 1 1 1
    France The Netherlands Spain
  • Study on ABCB5+ MSCs for Recessive Dystrophic and Junctional Epidermolysis Bullosa Patients

    Not yet recruiting

    3 1 1
    Austria Croatia Denmark France Germany Greece +6
  • Study on the Effects of Mannan-Conjugated Birch Pollen Allergoids for Adolescents and Adults with Birch Pollen-Induced Allergic Rhinitis or Rhinoconjunctivitis

    Not recruiting

    3 1 1
    Germany

Glossary

  • Bioequivalence: A term used in pharmacology to describe the comparison of different formulations of a drug to ensure they have the same biological effects in the body.
  • Fexofenadine Hydrochloride: An antihistamine medication used to relieve allergy symptoms, also known by the brand name Allegra.
  • Allergic Rhinitis: An allergic inflammation of the nasal airways, commonly known as hay fever, causing symptoms such as sneezing, runny nose, and nasal congestion.
  • ST-segment Elevation Myocardial Infarction (STEMI): A severe type of heart attack where a coronary artery is completely blocked, causing part of the heart muscle to die.
  • Pseudoephedrine Hydrochloride: A decongestant medication often combined with antihistamines like Fexofenadine to treat allergy and cold symptoms.
  • Extended-Release (ER): A formulation of medication designed to release the active ingredient slowly over time, providing a longer-lasting effect.
  • Orally Disintegrating Tablet: A tablet designed to rapidly dissolve in the mouth without the need for water, making it easier to take for some patients.
  • Placebo: An inactive substance or treatment used in clinical trials as a control to compare against the effects of the drug being tested.
  • Cardiac Fibrosis: The formation of excess fibrous connective tissue in the heart, which can occur after a heart attack and impair heart function.
  • Left Ventricular Ejection Fraction (LVEF): A measurement of how much blood the left ventricle pumps out with each contraction, used to assess heart function.

References

  1. https://clinicaltrials.gov/study/NCT02175485
  2. https://clinicaltrials.gov/study/NCT00637455
  3. https://clinicaltrials.gov/study/NCT00637611
  4. https://clinicaltrials.gov/study/NCT00637884
  5. https://clinicaltrials.gov/study/NCT01888718
  6. https://clinicaltrials.gov/study/NCT01066754
  7. https://clinicaltrials.gov/study/NCT01133470
  8. https://clinicaltrials.gov/study/NCT06548204